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supply is limited by how many people are willing to donate their blood to blood bank. 
“What can we do about this chronic problem?” Every time we suffer the tragedy, we 
would ask the same question. 
 
With the advances in bio-technology and medical science, mankind should think 
about alternative way of solving this problem. Why do we need human blood for 
transfusions? Why can’t we use other liquids for transfusion instead? Why can’t we 
produce something to replace human blood in such emergency situations?  
 
Human blood can be broken down into four parts, white blood cells, hemoglobin, 
platelets and plasma. 
Artificial blood consists of other materials that work the same way as human blood.  
In our project study, we hope to make reader understand what artificial blood is. And 
which type is the best currently in emergency situation..  
 
3. Problem formulation 
Nowadays, there are many artificial blood products available. Three basic types of 
artificial blood are found: modified-animal blood, fluorocarbon-based blood and 
aloe-based blood.  
All of them are able to carry oxygen to the tissues and heart. But none of them can be 
used as a permanent replacement to the body. We would like to analyze the 
characteristics of these types of artificial blood to assess which type of artificial 
blood is the best blood substitute at this time. Also, will they be permanently 
available in the future, will be discussed. 
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Oncotic pressure also known as colloid osmotic pressure, which is an essential 
function of blood. Oncotic pressure is formed by large protein in plasma, which can 
not cross through the capillary walls easily. Its function is to “balance out the 
tendency for fluid to leak out of the capillaries”2. If the Oncotic pressure is too low, 
there will be overfull fluid buildup in tissue, thus cause edema. If situation is on the 
other way, then hypertension will be evolved by high fluid cross through capillary 
walls. We wonder if any blood substitute could easily generate an oncotic pressure. To 
produce an oncotic pressure which is similar to human blood, need 7g/dl proteins 
dissolve in the plasma.  
Oxygen affinity is coupled with P50, which is the partial pressure of oxygen at 
which hemoglobin is 50% saturated with O2. In terms of hemoglobin, the basic 
principle of P50 is when P50 goes up, oxygen affinity will fall down, and thus release 
more oxygen to tissue, and vice versa. Under normal condition, the value of P50 
should be akin to natural hemoglobin. 
 The best blood substitute must have a long shelf life, like 1 year or longer. We 
could image if we produce this kind of artificial blood in a large scale which has a 
shelf life of, for example, 3 months, and this product was not demanded enough, then 
it would be a waste of time and money. So long shelf life would make blood products 
more efficient and practical. Half life is used to measure the time that the substitutes 
actually working in the body. 
Cross-matching makes blood transfusions both complex and inconvenient. We 
absolutely should skip this procedure if possible with artificial blood substitutes.  
High quality blood substitute with little or no side effects certainly requires 
technology and expensive cost. The best artificial blood should not be too expensive, 
however, to prohibit its use. Expensive products are only available to the rich, which 
means the rest of people would be excluded from such a product based on price.  
As far as access, the material used to produce the blood substitutes must be 
abundant in our environment. Bovine-based hemoglobin, for example, is one example 
of a product for which the raw material is readily available.   
                                                        
2
 http://www.answers.com/oncotic%20pressure 
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oxygen and carbon dioxide, nutrients (to blood cells), ions (Na+, Ca2+), waste products, 
hormones, heat, water, electrolytes, antibodies and vitamins 
It also helps the body combat infections and disease.  As such, human blood plays a 
vital role in our immune system. And it keeps a relatively constant body temperature. 
These many functions are accomplished by the components of human blood. The main 
components of the human blood are red blood cells, white blood cells, platelets and 
fluid (plasma).  
 
 
Fig. 6.1  Red blood cells3 
6.1 Red cells: Red cells normally make up 40-50% of the total blood volume.4 The 
red color of blood is primarily due to oxygenated red cells. They transport oxygen from 
the lung to all of the living tissues of the body and carry away carbon dioxide. 
Hemoglobin is the protein that makes up 95% of a red cell. Each red cell has about 
                                                        
3
 
http://www.dac.neu.edu/biology/em/
 
4 http://anthro.palomar.edu/blood/blood_components.htm 
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globin synthesized, once the “hole” which is used to accommodate hemachrome 
formed, hemachrome will combine with the globin and cause the globin to fold to 
form its final stereostructure which is called a αβ dimer. As Fig. 6.2 illustrates, we can 
divide the figure into two parts by cutting from the middle of the figure. Each part is 
called a αβ dimer. Two αβ dimers form a α2β2 tetramer which is named hemoglobin.  
Normally the hemoglobin of a healthy adult consists four polypeptide chains. Each 
polypeptide chain consists of a heme group and a single oxygen-binding site as Fig. 
6.2 illustrates. Two of the chains are α chains, also called α idenes. Each α idene has 
141 7amino acids. The other two chains are β chains which also called β idenes. Each 
β idene has 146 8amino acids. All these four chains arrange as a tetrahedron. It forms 
a globular molecule the diameter of which is 55 angstroms (1 angstrom = 10-11 meter)9. 
Under the cooperation of residue folded chain, iron which is on the center position of 
hemachrome, combines with oxygen. The structure of hemoglobin is stable but the 
oxygen affinity is very weak. When oxygen binds at one heme of one polypeptide 
chain, there will be a structural change. This facilitates oxygen binding at other hemes 
of other polypeptide chains in the same hemoglobin molecule. The structure changes 
at interfaces between these four polypeptide chains. So the whole structure of 
hemoglobin will change and all the hemes will combine with oxygen more easily. 
This cooperation allows each hemoglobin molecule can deliver 1.8310 times more 
oxygen than the hemoglobin molecule without the cooperation. 
 
 
                                                        
7
 http://www.biox.cn/content/20050828/35913.htm(in Chinese) 
8
 http://www.biox.cn/content/20050828/35913.htm(in Chinese) 
9
 Blood Substitutes: principles, methods, products and clinical trials Author Thomas Ming Swi Chang, Montreal, 
P.Q. Chapter 3 What are modified hemoglobin blood substitutes? Page 23 
10
 Blood Substitutes: principles, methods, products and clinical trials Author Thomas Ming Swi Chang, Montreal, 
P.Q. Chapter 3 What are modified hemoglobin blood substitutes? Page 25 
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 (Fig. 6.3.1) 12  Neutrophils(50～70～): Neutrophils are the most 
abundant of the white blood cells. Neutrophils go through the capillary walls and into 
infected tissue and kill the invaders (e.g., bacteria). 
 
 (Fig. 6.3.2) 13  Eosinophils(1 ～ 4％ ): Normally, the content of 
Eosinophils in blood is very low. Their numbers increase sharply in diseases, 
especially infections by parasitic worms. 
 
 (Fig. 6.3.3)14 Basophils(0～1％): Basophils are the least common 
of the white blood cells. But the number of basophils increases also during infection. 
They filled with granules of toxic chemicals that can digest micro-organisms. So that 
basophils are responsible for the symptoms of allergy in human immune system. 
 
 (Fig. 6.3.4) 15  Lymphocytes(20 ～ 40 ％ ): Lymphocytes are 
                                                        
12
 
http://www.piramoon.com/Clinical-Centrifuge-for-Medical-Diagnoses.htm
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http://www.piramoon.com/Clinical-Centrifuge-for-Medical-Diagnoses.htm
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http://www.piramoon.com/Clinical-Centrifuge-for-Medical-Diagnoses.htm
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http://www.piramoon.com/Clinical-Centrifuge-for-Medical-Diagnoses.htm
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as allergens. End they are involved in the protection against mutated cells, such as 
cancer 
 
 
Fig. 6.4  platelets19 
6.4 Platelets: Platelets are the abnormity morphology corpuscles that 
comparted by bone marrow megakaryocyte(a kind of cell that have giant nuclei). 
They can only be found in mammalian blood. Under normal conditions there are 
100-30020 thousand platelets per cubic millimeter in human blood. And they have 
a-8-1221- day-life in the blood. Platelets’ main function is concerned with cruor. 
When the bodily tissues are injured and bleeding. Usually, platelets congregated in 
large numbers for accelerating blood coagulation. So that platelets carry the 
function of stopping bleeding. If the concentration of platelets is low than 70 
thousand per cubic millimeter it will difficult for stopping bleeding. When the 
concentration of platelets is low than 40 22  thousand per cubic millimeter 
spontaneous hemorrhage will happens. 1960s, scientists had been substantiated 
that platelets have the function of engulfing virus, bacteria and other particulates. 
                                                        
19 http://www.netdoctor.co.uk/diseases/facts/thrombocytopenia.htm 
20 http://www.newhealth.com.cn/doc/rtzs/file1-105.html 
21 http://www.newhealth.com.cn/doc/rtzs/file1-105.html  
22 http://www.cnm21.com/dictionary/yycd_191.HTM 
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Plasma transports materials needed by cells and materials that must be removed from 
cells:25various ions (Na+, Ca2+) , glucose and traces of other sugars , amino acids , 
other organic acids , cholesterol and other lipids , hormones and wastes. 
In plasma, the osmotic pressure formed by inorganic salt is called crystal osmotic 
pressure and formed by plasma proteins we called colloid osmotic pressure. Plasma 
osmotic pressure is the summation of crystal osmotic pressure and colloid osmotic 
pressure. Plasma colloid osmotic pressure has great significance to retain the balance 
of blood and tissue fluid. In plasma colloid osmotic pressure’s high and low lies to the 
content of plasma protein. Because plasma protein is liable to drink deep of water, 
when colloid osmotic pressure debase, fluid of tissue making will manifold. Tissue 
clearance fluid accumulates will result in edema (Edema is an observable swelling 
from fluid accumulation in certain body tissues).26 When colloid osmotic pressure is 
too high, human body will be dehydrated (A condition caused by the loss of too much 
water from the body).27 My guess: If human body hasn’t colloid osmotic pressure, 
human body can’t retain the balance of blood and tissue fluid. In particular, plasma 
protein will not absorb water. So the body will be burst by tissue fluid.   
Among the main components of human blood, we think red blood cell is the most 
relevant to our project and problem formulation. Because the most important function 
of blood is transporting oxygen by red blood cells. And the emphasis of researching is 
the red blood cells substitute.  
6.6 Blood match cross problem 
The A blood human red blood cell surface has the A antigen. In their blood serum it 
can produce antibody to resist the B antigen. A blood-group only can accept A- for 
A-'s person or O-'s blood. The B blood person is opposite of the A blood person, their 
red blood cell surface has the B antigen. In the blood serum it can produce antibody to 
                                                        
25 http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/B/Blood.html 
26 http://www.medicinenet.com/edema/article.htm 
27 http://www.stjude.org/glossary?searchTerm=D 
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Fig. 6.7  The oxygen dissociation curve. 28 
Form the figure above, the curve can be divided into three parts: 
The right side of the curve has a high partial pressure about 60-100 mmHg which 
describes the situation in lungs. This part of the curve is flat, which means the changes 
of partial pressure of oxygen have a little effect to the oxygen saturation of hemoglobin. 
That is why the oxygen saturation of hemoglobin can maintain over 90% and people 
won’t cause hypoxemia when at high elevations or when suffering from respiratory 
diseases. Under these situations, the hemoglobin is still able to bind with enough 
oxygen to satisfy the oxygen need of tissues.  
The middle piece of the curve is steep and the range of partial pressure of oxygen is 
about 40-60 mmHg. The saturation of hemoglobin decreases fast when the partial 
                                                        
28
 http://pharyngula.org/~pzmyers/MyersLab/teaching/Bi104/l07/img/pO2.gif 
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goes down or the pressure of CO2 in blood decreases, P50 also decreases. And P50 is 
directly proportional to the concentration of 2,3-DPG, which means it increases as the 
concentration of 2,3-DPG also increases. These relationships are showed in the 
following figure X.  
 
Fig. 6.8 This is an oxygen dissociation curve. Hemoglobin is 100% saturated with oxygen at an oxygen tension 
of 100mmHg in the lung capillaries. The P50 curve shifts to right as pH decreases, the pressure of CO2 
increases, the temperature increases or the concentration of 2,3-DPG increases.30 
If pH increases, P50 decreases and the oxygen affinity of hemoglobin increases. 
Oppositely, if pH decreases, P50 increases. This is known as Bohr Effect. 
The effect caused by the pressure of CO2 is similar to the effect caused by pH. If the 
pressure of CO2 increases, CO2 combines with H2O forms H2CO3, H2CO3 is 
                                                        
30
 http://www.frca.co.uk/images/ODC_3.jpg  
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is high, the experiments using unmodified hemoglobin were stopped.32 Hemoglobin 
which is separated from the red blood cell has the following problems33: 
 
 
 
 
 
 
 
 
Fig. 6.9 The function of 2,3-DPG in regards to oxygen affinity ofhemoglobin On the left 
side is hemoglobin without 2,3-DPG which has a high oxygen affinity and on the right side 
is on the contrary.34 
6.9.1  
There is a substance which is called 2,3-diphosphoglyerate(2,3-DPG) in the red blood 
cell. It can adjust the ability of hemoglobin oxygen transport and can decrease the 
oxygen affinity of hemoglobin. That means increasing with 2,3-DPG, the oxygen 
affinity of hemoglobin will decrease, causing more off loading of O2 to  the tissues. 
2,3-DPG is not available in plasma but is found in the red blood cells themselves.. If 
hemoglobin separated from the red blood cell loses 2,3-DPG, the oxygen affinity of 
hemoglobin will become high and P50 will be low, it can’t supply more oxygen to 
                                                        
32
 http://www.sciencetimes.com.cn/col36/col78/article.htm1?id=60629(in Chinese) 
33
 http://www.sciencetimes.com.cn/col36/col78/article.htm1?id=60629(in Chinese)  
34
 http://www.mfi.ku.dk/ppaulev/chapter8/images/8-3.jpg 
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6.9.3  
If hemoglobin is separated from the red blood cell, the structure will be unstable and the 
four polypeptide chains will be decomposed easily into small molecular degradation 
products (dimers). These dimers can be filtered quickly by kidney but they are also 
toxic to the kidney.  
6.9.4 
Endothelial cells can release nitric oxide into the interstitial space of vessel walls. Nitric 
oxide can cause the smooth muscle of the vessel wall to be relaxed. That means 
increasing with nitric oxide the blood vessel will be dilated. Oppositely, low nitric 
oxide can cause vasoconstriction. Hemoglobin has a high affinity for nitric oxide and it 
can combine with nitric oxide, reducing its concentration and causing blood vessel 
constriction and increasing blood pressure. People who have high blood pressure can be 
at risk in such cases. 
6.9.5  
Due to oxidation, some methaemoglobin is produced in the red blood cells. There are 
NADH dehydrogenase and NADPH dehydrogenases in the red blood cells which can 
deoxidize methaemoglobin to hemoglobin. Due to the deoxidization system, the 
methaemoglobin is kept in a low level. Hemoglobin which is separated from the red 
blood cell can be oxidized into methaemoglobin easily without modulation of 
reductase. It will then lose its oxygen carrying capacity.  
The hemoglobin molecule must be able to on-load oxygen from the lungs and off-load 
it at the tissues to be able useful. The ability of a blood substitute to on-load oxygen in 
lungs is generally known as its oxygen carrying capacity. 
From above we know we should modify hemoglobin in following ways: 
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matching problem（has been talked before）. The synthetic membrane doesn’t have 
blood group antigens on it, as a result, it can transport to any blood group type.  
Another way to modify hemoglobin for use as an artificial blood substitute is to 
produce crosslinked hemoglobin. People use a bifunctional agent to crosslink some of 
the amino groups which are on the surface of the hemoglobin molecule to prevent 
hemoglobin tetramers from breaking down into two dimers. One of bifunctional 
agents is named sebacyl chloride, the reaction is as follows40: 
 
And in 1971, another bifunctional agent was used to form crosslinked hemoglobin for 
artificial blood cells which is called glutaraldehyde. The reaction is as follows41: 
 
Crosslinking hemoglobin with glutaraldehyde makes the enzymes and crosslinked 
proteins more stable in a soluble state. It also makes the steric less complicated and 
substrates diffuse more easily. Then during next few years, other bifunctional 
crosslinkers were used to form crosslinked hemoglobin, such as N-maleimidomethyl 
which is crosslinked inside each hemoglobin molecule between the β polypeptide 
chains and last the circulation time. The discovery of pyridoxal phosphate, which has a 
similar function as 2,3-DPG, more crosslinked hemoglobins are put into use. 
Modern development of modified hemoglobin is based on an understanding of the 
structure-function relationship of hemoglobin.42 Hemoglobin consists of many reactive 
amino groups. There are 40 reactive lydsines, many of which are on the surface of 
                                                        
40
 Blood Substitutes: principles, methods, products and clinical trials Author Thomas Ming Swi Chang, Montreal, 
P.Q. Chapter 3 What are modified hemoglobin blood substitutes?  Modification of hemoglobin by 
microencapsulation and crosslinking Page 16  
41
 Blood Substitutes: principles, methods, products and clinical trials Author Thomas Ming Swi Chang, Montreal, 
P.Q. Chapter 3 What are modified hemoglobin blood substitutes?  Modification of hemoglobin by 
microencapsulation and crosslinking Page 17  
42
 Blood Substitutes: principles, methods, products and clinical trials Author Thomas Ming Swi Chang, Montreal, 
P.Q. Chapter 3 What are modified hemoglobin blood substitutes?  Modification of hemoglobin by 
microencapsulation and crosslinking Page 19  
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The viscosity is 1.3centipoise and P50 is 38mmHg45.  
 
Clinical experiment shows that it is effective in maintaining a patient’s exercise 
capacity after acute anemia (Acute - Anemia is characterized by a reduction in the 
number of circulating red blood cells, the amount of hemoglobin, or the volume of 
packed red blood cells. And anemia is classified as acute or chronic.)46. This may be 
related to an enhancement of oxygen on-loading and off-loading as shown by increase 
in pulmonary diffusing capacity (the ability of the alveolocapillary membrane to 
transfer gas form pulmonary)47 in normal volunteers.  
 
And now the blood substitute produced from bovine hemoglobin based on two main 
kinds of modified bovine hemoglobin48: 2-Nor-2-formylpyridoxal (NFPLP) modified 
bovine hemoglobin and polyethylene glycol (PEG) modified bovine hemoglobin. 
NFPLP modified bovine hemoglobin is form making 2-Nor-2-formylpyridoxal 
molecule covalently coupling bonded on bovine hemoglobin molecule. PEG modified 
bovine hemoglobin is form making polyethylene glycol molecule covalently coupling 
bonded on amino acids on the surfaces of multi-bovine hemoglobin, and come into 
being polymerized macromolecule.   
 
                                                        
45 <Blood substitutes: Principles, Methods, Products and Clinical Trials > (T.M.S. Chang) 
46 http://www.emedicine.com/emerg/topic808.htm 
47http://www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspzQzpgzEzzSzppdocszSzuszSzcommonzSzdorlandszSzdorlandzSz
dmd_c_05zPzhtm 
48 http://www.sciencetimes.com.cn/col36/col78/article.htm1?id=60629 
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a fluorescence technic)51 will be extended. The bovine hemoglobin needed to be 
chemically altered at a molecule level. The hemoglobin was covalently bonded with a 
few chemical groups to improve in particular the biocompatibility of macromolecule 
by artificially altering their side chain radical. In that way, modified bovine 
hemoglobin would have less toxic side effects when used as a kind of blood 
substitute.  
 
We found the following advantages of bovine hemoglobin as a blood substitute. 
Foremost, bovine hemoglobin production doesn't require refrigeration, and it's stable 
at room temperature that can have a three-year shelf life.52 . Secondly, bovine 
hemoglobin production doesn’t have the problem of cross matching for different type 
blood. Thirdly, the blood substitute based on bovine hemoglobin has great effect on 
the curing of hemorrhagic shock. And they also have great effect on protecting 
Cardiovascular and kidney53. Finally, production of modified hemoglobin from a 
bovine source can reduce the costs of the production.  
 
7.3 Fluorocarbon-based blood substitutes: 
To modify human or animal hemoglobin is one of the ways to create a blood 
substitute and thus help solve the problem of lack of replacement blood. The other 
way is to use materials other than hemoglobin. Thus, fluorocarbon chemicals were 
invented to replace the function of hemoglobin.  
7.3.1 Why fluorocarbon can be considered as an oxygen carrier?  
PFC is able to carry and release high volume oxygen to tissue, which is even more 
                                                        
51 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=5097370&dopt=Abstract 
52 http://www.findarticles.com/p/articles/mi_m0IBP/is_12_46/ai_95791154 
53 http://www.wanfangdata.com.cn/qikan/periodical.Articles/gwyx-mzxyfsfc/gwyx2004/0405/040508.htm 
 
 
1st Semester Project: Artificial Blood  
Group 7 
Page 31 of 46 
volume of physically dissolved gas relies on the solubility coefficient for that gas of 
the PFCs utilized, and is proportional to the gas’ partial pressure.  
This situation leads to several-fold increase of the oxygen concentration in PFCs 
emulsion by increasing oxygen concentration in the air inspired by the patient. 
 
Because of the weak interaction between oxygen molecules and PFCs, the release of 
O2 to tissues is greatly enhanced and extraction rates and ratios are a lot higher with 
PFCs, which is able to reach 90% oxygen of its carrying, compared to only 25-30% 
for hemoglobin58.  
 
PFCs are non-reactive, and very stable for chemical properties. 
 
7.3.4 Other issues: 
PFCs are actually insoluble in water, they have to be formulated into 
emulsion, and thus the viscosity is yet higher than that of 
hemoglobin, which consequently delivers oxygen to tissue in a 
relatively low speed.   
Some side-effect of using PFC’s has been noted.  : Conscious 
volunteers receiving an infusion of PFC product called Fluosol®, 
felt headaches and occasional lower backaches. They also had 
delayed effects (2-12 hr) with flu-like symptoms, e.g. fever, chills, nausea59) and these 
are all the side-effect can be found, 
 
There are two kind of PFC available on the market, Fluosol® and Oxygent™. 
Oxygent™ carrying capacity is stronger than Fluosol®.  
 
                                                        
58
 T.M.S Chang Blood substitutes: Principles, Methods, Products and Clinical Trials 1997 Vol. 2 P106 
59
 Flaim SF. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Art Cells Blood Subs 
Immob Biotech 1994; 24:81-90 
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Figure 1 
A package of Artificial Blood Power 
7.4.2 Lugworm’s Blood 
 
Arenicola marina is a burrowing marine annelid which is common in muddy estuaries 
and sandy beaches from the middle shore downwards. 61  Its presence is often 
indicated by holes and casts which mark the entrances to its J-shaped burrow. They 
are wide spread around British and Irish coasts. It is also an important food source for 
wading birds such as curlew and godwits. It has been recently discovered, that 
lugworms provide a good material for Artificial Blood as well. Frank a professor from 
France said,” The result of transfusion from lugworms’ blood to human is extremely 
satisfying.”62 The reason why is, hemoglobin in lugworms is quite similar with the 
human’s. And the characteristics of the lugworms’ hemoglobin indicate it has 
advantages of storage and injection. Nowadays, scientists are not satisfied with the 
artificial blood from other animals or combined from chemicals because many people 
have allergic reactions to these kinds of blood compounds. Some people even reject 
them outright. Such allergic or rejection reactions have not been seen with Lugworm 
                                                        
61
 (http://www.tiscali.co.uk/reference/encyclopaedia/wildlife/invertebrates_lugworm.html) 
62
 http://www.usetm.com/info/ReadNews.asp?NewsID=1241&BigClassID=48&SmallClassID=39&SpecialID=0 
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They took out some blood from each mouse. Afterwards the mice in one group were 
injected Aloe Extract and the ones in another group were injected physiological saline 
solution. As a result, there are 8 mice survived in the first group and 5 in another. In 
another experiment, the scientists took out more blood of each new mouse. After 2 
hours, 5 out of 15 which injected Aloe Extract alive, on another hand, 1 of 14 alive. 
Seven animals receiving no treatment all died within 35 minutes.64 According to the 
experiments, it is obvious that Aloe Extract has good potential for a temporary blood 
substitute. But the remarkable point is it just can be use for emergency not for long. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
A normal kind of Aloe 
 
 
 
 
 
 
                                                        
64
 (http://www.msnbc.msn.com/id/5518687/) 
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Bovine-based hemoglobin product can be stored for 3years. PFCs and Modified 
hemoglobin have a little shorter shelf life. And natural blood from donors is only 
available for 35-42 days.  
 
The natural blood from donors is able to efficiently work in body 17 days long. 
Modified hemoglobin and bovine-based hemoglobin share the same half life, 24 hours, 
which is much shorter than natural blood. And PFCs are even shorter; they only stay 
in body 8 – 30 hours.  
The source of natural blood from donors is limiting. Because it is only generate by 
human. The modified hemoglobin shares the same main resource with natural blood, 
although the recombinant and transgenic also can be developed as artificial 
hemoglobin. Therefore, it is also limiting for modified hemoglobin.  
 
Without doubt, the source of bovine-based hemoglobin is cows, which abundantly 
exist in our life.  To produce PFCs just need a kind of organic matters, Hydrocarbons 
analogs, which are not hard to find out. 
 
9. Discussion  
As previous chapter introduced, there are two approaches to the blood substitute. The 
first approach is using modified hemoglobin, which is including both human and 
bovine hemoglobin. The other one is use pure man-made compounds, namely 
perfluorochemicials. This approach adopts a chemical method to carry oxygen to 
tissues, which completely takes non-hemoglobin materials, and thus, up to a point, is 
a break with the notion that blood substitute can’t be produced by other materials than 
hemoglobin per se. 
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9.1 Oxygen delivery ability 
Hemoglobin solutions have a sigmoid oxygen dissociation curve that is similar to 
hemoglobin of human blood. PFC emulsions have a linear relationship between 
oxygen partial pressure and saturation. As showed in Fig. 9.1.1. This means that at a 
low oxygen partial pressure, enough oxygen can be offloaded. In contrast, PFC 
emulsions need a high oxygen partial pressure to offload maximum oxygen.  
 
 
Fig. 9.1.166  
We assume both PFC emulsions and hemoglobin offload 5 Vol% oxygen. From Fig. 
9.1.1 we can see, the oxygen extraction of hemoglobin is 25% compared with 90% 
oxygen extraction of PFC emulsions. That means PFC emulsions deliver oxygen is 
more completely than blood delivered. In other words, PFC emulsions have high 
oxygen delivery ability. 
Modified hemoglobin solutions have a higher P50, we can also compare modified 
hemoglobin solutions and hemoglobin in real human blood. As showed in Fig. 9.1.2 
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According to our comparison，Modified Hemoglobin and Bovine Hemoglobin do not 
have any noticeable difference in oxygen carrying capacity compared to human 
hemoglobin. That is an acceptable situation, but it could be improved. In near future, 
the hemoglobin combined with new efficient enzyme which works like a catalyzer 
that would accelerate the reaction speed would make a big step forward on oxygen 
carrying capacity. As a result, a small amount of Modified or Bovine Hemoglobin 
could supply a similar amount of oxygen compared to a large amount of human 
blood. 
 
PFCs represent a special oxygen carrier compare with other types of Artificial Blood 
being the only chemical compound with a very high carrying capacity for O2. But this 
special chemical is also associated with some problems. For example, it is not a 
natural animal product. The lungs may not adapt to it absolutely. Furthermore, it 
sometimes will cause spine-ache and cold-like symptoms. But these problems will 
decrease as the components of PFC are further modified. 
 
Early clinical information following the infusion of hemoglobin resulted in significant 
filtering by the kidney. It was concluded that hemoglobin was not suitable oxygen 
carrying therapeutically in its native tetrameric form. The chemical modifications of 
hemoglobin to stabilize the tetramer have significantly reduced removal of 
hemoglobin by kidney.68 
 
Artificial Blood has been studied since 1972, but it is still only known by very few 
people. For one reason, only a few scientists work on it and not enough information 
has been provided to the press, for example. On the other hand, the Moslem 
communities, by their Islamic laws, condemn the using of blood in transfusion. More 
seriously, the Christians of the Jehovah's Witnesses faith are not allowed to accept 
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patients must go to the hospital every 1 or 2 days and it is impossible to lead a normal 
life. As hemoglobin is a protein, another possibility is to stimulate Modified 
Hemoglobin to multiple themselves. If this is possible, the once such a product was 
used, it may work for patient’s whole live. 
 
As mentioned, Modified Hemoglobin should become more suitable and available in 
future. Thus shortage of blood should not be as large a problem in the future. One 
possibility is that people might possibly like to substitute their blood with such 
products, even when they are healthy, because the Modified Hemoglobin functions 
much better than human hemoglobin in future and has no side effects. As an example, 
for the more oxygen you get, you can work more efficiently, think faster and do not 
feel tired. There will be a possibility that the athletes who beat the world’s records in 
future normally have use the Artificial Blood. And later the Artificial Blood would 
have been banned as analeptic for athletes, because it is really strong. 
 
10. Conclusion 
In a nutshell, PFCs are outstanding among the other substitutes which are the best 
substitutes under emergency situation. 
On the other hand, modified and bovine-based hemoglobin both are akin to the natural 
hemoglobin, which are liable to be adjusted by human body. If the situation is not at 
high risk, and patients do not have allogeneic blood at hand, we recommend using 
modified or bovine-based hemoglobin as transfusion blood.  
 
With the advance in bio-technology, there will be more blood substitutes available, 
which could permanently replace the natural blood. The substitute holds this kind of 
promise is artificial blood powder.  
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